ID   SIGL9_HUMAN             Reviewed;         463 AA.
AC   Q9Y336; Q6GTU4; Q9BYI9;
DT   08-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 2.
DT   03-AUG-2022, entry version 188.
DE   RecName: Full=Sialic acid-binding Ig-like lectin 9;
DE            Short=Siglec-9;
DE   AltName: Full=CDw329;
DE   AltName: Full=Protein FOAP-9;
DE   AltName: CD_antigen=CD329;
DE   Flags: Precursor;
GN   Name=SIGLEC9; ORFNames=UNQ668/PRO1302;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=10903842; DOI=10.1006/geno.2000.6208;
RA   Foussias G., Yousef G.M., Diamandis E.P.;
RT   "Identification and molecular characterization of a novel member of the
RT   siglec family (SIGLEC9).";
RL   Genomics 67:171-178(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10801862; DOI=10.1074/jbc.m002788200;
RA   Zhang J.Q., Nicoll G., Jones C., Crocker P.R.;
RT   "Siglec-9, a novel sialic acid binding member of the immunoglobulin
RT   superfamily expressed broadly on human blood leukocytes.";
RL   J. Biol. Chem. 275:22121-22126(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND MUTAGENESIS OF ARG-120.
RC   TISSUE=Peripheral blood;
RX   PubMed=10801860; DOI=10.1074/jbc.m002775200;
RA   Angata T., Varki A.;
RT   "Cloning, characterization, and phylogenetic analysis of siglec-9, a new
RT   member of the CD33-related group of siglecs. Evidence for co-evolution with
RT   sialic acid synthesis pathways.";
RL   J. Biol. Chem. 275:22127-22135(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLU-315.
RA   Takayama K., Fujii Y., Turitani K., Naitou K., Kawaguchi A., Ukai Y.,
RA   Amemiya C., Yajima Y., Yazaki M.;
RT   "Molecular cloning of a novel gene, FOAP-9, which are induced by oxydized
RT   LDL in human macrophages.";
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS GLU-100 AND GLU-315.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Putative adhesion molecule that mediates sialic-acid
CC       dependent binding to cells. Preferentially binds to alpha-2,3- or
CC       alpha-2,6-linked sialic acid. The sialic acid recognition site may be
CC       masked by cis interactions with sialic acids on the same cell surface.
CC   -!- INTERACTION:
CC       Q9Y336; Q6PL45-2: BRICD5; NbExp=3; IntAct=EBI-12857926, EBI-12244618;
CC       Q9Y336; P62166: NCS1; NbExp=3; IntAct=EBI-12857926, EBI-746987;
CC       Q9Y336; P11686: SFTPC; NbExp=3; IntAct=EBI-12857926, EBI-10197617;
CC       Q9Y336; O00206: TLR4; NbExp=2; IntAct=EBI-12857926, EBI-528701;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y336-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y336-2; Sequence=VSP_054106;
CC   -!- TISSUE SPECIFICITY: Expressed by peripheral blood leukocytes
CC       (neutrophils and monocytes but not eosinophils). Found in liver, fetal
CC       liver, bone marrow, placenta, spleen and in lower levels in skeletal
CC       muscle, fetal brain, stomach, lung, thymus, prostate, brain, mammary,
CC       adrenal gland, colon, trachea, cerebellum, testis, small intestine and
CC       spinal cordon.
CC   -!- DOMAIN: Contains 1 copy of a cytoplasmic motif that is referred to as
CC       the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is
CC       involved in modulation of cellular responses. The phosphorylated ITIM
CC       motif can bind the SH2 domain of several SH2-containing phosphatases.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. SIGLEC (sialic
CC       acid binding Ig-like lectin) family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=Siglec-9;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Itlect_275";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF135027; AAD26428.2; -; Genomic_DNA.
DR   EMBL; AF247180; AAF87223.1; -; mRNA.
DR   EMBL; AF227924; AAF71455.1; -; mRNA.
DR   EMBL; AB026265; BAB41100.1; -; mRNA.
DR   EMBL; AY358913; AAQ89272.1; -; mRNA.
DR   EMBL; AK297043; BAG59570.1; -; mRNA.
DR   EMBL; AC011473; AAG23261.1; -; Genomic_DNA.
DR   EMBL; BC035365; AAH35365.2; -; mRNA.
DR   CCDS; CCDS12825.1; -. [Q9Y336-1]
DR   CCDS; CCDS56100.1; -. [Q9Y336-2]
DR   RefSeq; NP_001185487.1; NM_001198558.1. [Q9Y336-2]
DR   RefSeq; NP_055256.1; NM_014441.2. [Q9Y336-1]
DR   AlphaFoldDB; Q9Y336; -.
DR   SMR; Q9Y336; -.
DR   BioGRID; 118056; 12.
DR   IntAct; Q9Y336; 14.
DR   STRING; 9606.ENSP00000413861; -.
DR   ChEMBL; CHEMBL4105860; -.
DR   GlyGen; Q9Y336; 8 sites.
DR   iPTMnet; Q9Y336; -.
DR   PhosphoSitePlus; Q9Y336; -.
DR   BioMuta; SIGLEC9; -.
DR   DMDM; 25009270; -.
DR   EPD; Q9Y336; -.
DR   jPOST; Q9Y336; -.
DR   MassIVE; Q9Y336; -.
DR   PaxDb; Q9Y336; -.
DR   PeptideAtlas; Q9Y336; -.
DR   PRIDE; Q9Y336; -.
DR   ProteomicsDB; 85970; -. [Q9Y336-1]
DR   Antibodypedia; 2416; 603 antibodies from 33 providers.
DR   CPTC; Q9Y336; 1 antibody.
DR   DNASU; 27180; -.
DR   Ensembl; ENST00000250360.8; ENSP00000250360.2; ENSG00000129450.9. [Q9Y336-1]
DR   Ensembl; ENST00000440804.7; ENSP00000413861.2; ENSG00000129450.9. [Q9Y336-2]
DR   GeneID; 27180; -.
DR   KEGG; hsa:27180; -.
DR   MANE-Select; ENST00000250360.8; ENSP00000250360.2; NM_014441.3; NP_055256.1.
DR   UCSC; uc002pvu.4; human. [Q9Y336-1]
DR   CTD; 27180; -.
DR   DisGeNET; 27180; -.
DR   GeneCards; SIGLEC9; -.
DR   HGNC; HGNC:10878; SIGLEC9.
DR   HPA; ENSG00000129450; Tissue enhanced (lymphoid).
DR   MIM; 605640; gene.
DR   neXtProt; NX_Q9Y336; -.
DR   OpenTargets; ENSG00000129450; -.
DR   PharmGKB; PA35779; -.
DR   VEuPathDB; HostDB:ENSG00000129450; -.
DR   eggNOG; ENOG502S41V; Eukaryota.
DR   GeneTree; ENSGT01040000240469; -.
DR   HOGENOM; CLU_024444_6_1_1; -.
DR   InParanoid; Q9Y336; -.
DR   OMA; LSFQMVK; -.
DR   OrthoDB; 324083at2759; -.
DR   PhylomeDB; Q9Y336; -.
DR   PathwayCommons; Q9Y336; -.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SignaLink; Q9Y336; -.
DR   BioGRID-ORCS; 27180; 18 hits in 1061 CRISPR screens.
DR   ChiTaRS; SIGLEC9; human.
DR   GeneWiki; SIGLEC9; -.
DR   GenomeRNAi; 27180; -.
DR   Pharos; Q9Y336; Tbio.
DR   PRO; PR:Q9Y336; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q9Y336; protein.
DR   Bgee; ENSG00000129450; Expressed in monocyte and 99 other tissues.
DR   ExpressionAtlas; Q9Y336; baseline and differential.
DR   Genevisible; Q9Y336; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0030667; C:secretory granule membrane; TAS:Reactome.
DR   GO; GO:0030246; F:carbohydrate binding; NAS:UniProtKB.
DR   GO; GO:0033691; F:sialic acid binding; IBA:GO_Central.
DR   GO; GO:0007155; P:cell adhesion; IBA:GO_Central.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; NAS:UniProtKB.
DR   Gene3D; 2.60.40.10; -; 3.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR013106; Ig_V-set.
DR   Pfam; PF07686; V-set; 1.
DR   SMART; SM00409; IG; 3.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   PROSITE; PS50835; IG_LIKE; 3.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Disulfide bond; Glycoprotein;
KW   Immunoglobulin domain; Lectin; Membrane; Reference proteome; Repeat;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000255"
FT   CHAIN           18..463
FT                   /note="Sialic acid-binding Ig-like lectin 9"
FT                   /id="PRO_0000014949"
FT   TOPO_DOM        18..348
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        349..369
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        370..463
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          20..140
FT                   /note="Ig-like V-type"
FT   DOMAIN          146..229
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          236..336
FT                   /note="Ig-like C2-type 2"
FT   REGION          380..428
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          444..463
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           431..436
FT                   /note="ITIM motif"
FT   MOTIF           454..459
FT                   /note="SLAM-like motif"
FT   COMPBIAS        448..463
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         120
FT                   /ligand="N-acetylneuraminate"
FT                   /ligand_id="ChEBI:CHEBI:35418"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        101
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        138
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        161
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        225
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        231
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        238
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        256
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        334
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        36..170
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        41..102
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        164..213
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        272..320
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         402..463
FT                   /note="GPLTEPWAEDSPPDQPPPASARSSVGEGELQYASLSFQMVKPWDSRGQEATD
FT                   TEYSEIKIHR -> ILNHFIGFPTFLGLGFEFLLNLRDLCCHPDSEFYVYHFSHFRLIK
FT                   NIAGEIVWSLEGKILWLLDVSDFFHWFFLICVG (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054106"
FT   VARIANT         100
FT                   /note="K -> E (in dbSNP:rs2075803)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_014254"
FT   VARIANT         125
FT                   /note="S -> N (in dbSNP:rs200658)"
FT                   /id="VAR_014255"
FT   VARIANT         131
FT                   /note="K -> Q (in dbSNP:rs16988910)"
FT                   /id="VAR_033621"
FT   VARIANT         147
FT                   /note="N -> K (in dbSNP:rs273687)"
FT                   /id="VAR_014256"
FT   VARIANT         315
FT                   /note="A -> E (in dbSNP:rs2258983)"
FT                   /evidence="ECO:0000269|PubMed:15489334, ECO:0000269|Ref.4"
FT                   /id="VAR_014257"
FT   VARIANT         316
FT                   /note="A -> D (in dbSNP:rs273688)"
FT                   /id="VAR_014258"
FT   VARIANT         349
FT                   /note="V -> A (in dbSNP:rs273690)"
FT                   /id="VAR_033622"
FT   MUTAGEN         120
FT                   /note="R->K: Loss of sialic acid binding."
FT                   /evidence="ECO:0000269|PubMed:10801860"
FT   CONFLICT        269
FT                   /note="R -> H (in Ref. 2; AAF87223)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   463 AA;  50082 MW;  807BDCE0D18191F2 CRC64;
     MLLLLLPLLW GRERAEGQTS KLLTMQSSVT VQEGLCVHVP CSFSYPSHGW IYPGPVVHGY
     WFREGANTDQ DAPVATNNPA RAVWEETRDR FHLLGDPHTK NCTLSIRDAR RSDAGRYFFR
     MEKGSIKWNY KHHRLSVNVT ALTHRPNILI PGTLESGCPQ NLTCSVPWAC EQGTPPMISW
     IGTSVSPLDP STTRSSVLTL IPQPQDHGTS LTCQVTFPGA SVTTNKTVHL NVSYPPQNLT
     MTVFQGDGTV STVLGNGSSL SLPEGQSLRL VCAVDAVDSN PPARLSLSWR GLTLCPSQPS
     NPGVLELPWV HLRDAAEFTC RAQNPLGSQQ VYLNVSLQSK ATSGVTQGVV GGAGATALVF
     LSFCVIFVVV RSCRKKSARP AAGVGDTGIE DANAVRGSAS QGPLTEPWAE DSPPDQPPPA
     SARSSVGEGE LQYASLSFQM VKPWDSRGQE ATDTEYSEIK IHR
//
